Introduction
Glioma is the most common primary tumor of the brain in adults and glioblastoma, the most malignant type of glioma, is nearly always fatal with a median post-treatment survival of less than one year (Grant et al., 1995) . Previous studies have demonstrated that human gliomas, like many other solid tumors, develop through multiple steps of genetic alterations from tumors of grades I and II to more malignant tumors of grades III and IV, based on the WHO classi®cation (Kleihues et al., 1993) . These alterations include frequent loss of loci on chromosomes 9p, 10, 11p, 13q, 17p, 19q and 22q (Fults et al., 1990; Sonoda et al., 1995a; Collins and James, 1993; Lang et al., 1994) , aberrations of the p53 gene (Mashiyama et al., 1991; von Deiming et al., 1992) and/or the MTS1/p16 gene (Kamb et al., 1994; Jen et al., 1994; Sonoda et al., 1995b; Izumoto et al., 1995) , and ampli®cation of the c-erbB1, MDM2 and/or PDGFRA genes (He et al., 1994; Hunter et al., 1995; Kumabe et al., 1992) .
Among these abnormalities, loss of loci on chromosome 10 is the most common genetic change detected in human gliomas and has been reported to be a late event in glioma formation (James et al., 1988; Fujimoto et al., 1989; Fults et al., 1990; Lang et al., 1994) . As several studies have demonstrated that at least three distinct regions of chromosome 10, including one region on 10p and two regions on 10q, are commonly deleted in glioblastoma DNAs, multiple tumor suppressor genes are likely to be present on this chromosome (Fults et al., 1992; Fults and Pedone, 1993; Karlbom et al., 1993; Rasheed et al., 1995; Albarosa et al., 1996; Sonoda et al., 1996) . Recently, the PTEN/MMAC1 gene on 10q23 was isolated and found to be mutated in some gliomas (Li et al., 1997; Steck et al., 1997) . However, there have been few reports concerning putative tumor suppressor genes on 10p (Steck et al., 1995; Sonoda et al., 1996; Kimmelman et al., 1996) .
In the present study, we focused on region(s) on the short arm of chromosome 10 harboring potential tumor suppressor genes. The results from two independent approaches, extensive deletion mapping of 79 glioma DNAs and genetic complementation experiments by transfer of human 10p fragments into the human glioblastoma cell line T98G, suggested that putative glioma suppressor gene(s) were located in the regions on 10p14 ± p15.
Results
Analysis of glioma DNAs for loss of heterozygosity at loci on chromosome 10 DNA from 79 gliomas was examined for LOH at loci on the short arm of chromosome 10 using 30 polymorphic microsatellite markers together with that on the long arm using 10 markers (Table 1) . Subchromosomal locations of these markers were determined using the GENE BRIDGE 4 Radiation Hybrid panel.
Representative results of LOH analyses are shown in Figure 1 . DNA from peripheral blood leukocytes was analysed and patient 8 was shown to be heterozygous at the loci of D10S552, D10S189, D10S1168 and D10S520. In DNA from this patient's tumor, heterozygosity was lost at all four of these loci. In patient 104, LOH was observed at the D10S189 and D10S1168 loci but not at the D10S552 and D10S520 loci. DNAs from patients 9 and 11 ( Figure 1 ) and others were analysed similarly. The results indicated that 23 of 33 glioblastomas (grade IV) (70%) showed LOH at loci on chromosome 10, while less frequent LOH was observed in grade III (10 of 29, 34%) and low-grade (four of 17, 24%) gliomas.
Among the 37 tumors with LOH at chromosome 10 loci, 20 (including tumors from patients 8 and 11 in Figure 1 ) showed loss of an entire chromosome 10. In the remaining 17 gliomas, partial loss of regions of chromosome 10 was observed (including tumors in patients 104 and 9 in Figure 1) . The results are summarized in Figure 2 . In the six tumors shown in Figure 2a , LOH was detected at loci only on the long arm of chromosome 10. LOH at loci only on the short arm was observed in four tumors (Figure 2b ). The remaining seven tumors showed LOH at loci on both arms (Figure 2c ).
On the basis of the pro®les observed in tumors with LOH at loci on the short arm of chromosome 10 ( Figure 2b and c), two separate regions were candidates for the loci of putative tumor suppressor genes. The ®rst region with a genetic distance of 5.6 cM on 10p15 was de®ned by the markers D10S1691 in tumor from patient 10 and D10S1649 in tumors from patients 3, 6 and 12. The second region with a genetic distance of 5.5 cM on 10p14 was de®ned by the markers D10S585 in tumor from the patient 9 and D10S1664 in tumors from patients 3 and 10. On the long arm of chromosome 10, the region including the D10S516 locus close to the PTEN/MMAC1 gene was frequently deleted in our panel of gliomas.
Transfer of fragments of chromosome 10 into T98G cells Detection of tumor suppressor activity is an alternative way of localizing the corresponding genes on a T   8  104  8  104  8  104  8 104 11 9 11 9 11 9 11 9
Figure 1 LOH analysis at the polymorphic loci on chromosome 10 in human gliomas. N and T indicate normal and tumor DNAs, respectively, from individual patients. Signals lost in tumor DNAs are indicated by arrowheads particular chromosomal region. For this functional approach, we introduced fragments of normal chromosome 10 into the glioblastoma cell line T98G by the microcell-mediated chromosome transfer (MMCT) method. This cell line showed hemizygosity at all the polymorphic loci examined on chromosome 10, indicating total loss of one chromosome. In the ®rst experiment, microcells isolated from mouse-human hybrid HA(10)A cells carrying human chromosome 10 tagged with the neomycin resistance gene on the short arm were fused with T98G cells and three hybrid clones (M1, M2 and M3) were obtained after G418 selection. Although T98G cells were reported to be tumorigenic when injected into nude mice subcutaneously (Stein, 1979) , we were unable to elicit any tumors from the T98G line for 15 weeks after injection of up to 5610 7 cells. Therefore, to analyse malignant phenotypes, we tested colony forming ability in soft agar of hybrid clones and the parental cell line instead of tumorigenicity in nude mice. As indicated in Table 2 , T98G cells formed 296 colonies in soft agar from 10 000 inoculated cells after 6 weeks of incubation. In contrast, none of the hybrid clones inoculated with the same numbers of cells formed any colonies except one in the case of clone M2. These results clearly indicated ecient suppression of colony forming ability of the T98G cells by introduction of portions of chromosome 10.
In the second experiment, microcells were irradiated, and fragments of human chromosome 10 thus produced were transferred into T98G cells. After fusion and G418 selection, 13 clones (R1 ± R11, R12, and R13 clones from irradiated microcells of HA (10)A cells with 5, 8 and 10 kRad of gamma-ray, respectively) were obtained. Colony forming ability in soft agar of these 13 hybrid clones was tested. The results are summarized in Table 2 . Three clones (clones R1, R11 and R13) gave relatively high numbers of colonies, while the 10 other clones had signi®cantly lost this ability.
As shown in Figure 3 , morphologies of the hybrid clones with suppressed colony-forming ability were not signi®cantly dierent from that of the parental T98G cell line. 
123 (42) 230 (78) 232 (78) Structural analysis of the chromosome 10 fragment retained in each hybrid
The chromosome 10 fragments retained in each of hybrid clones were analysed to determine the region harboring putative glioma suppressor gene(s). Highly polymorphic microsatellite markers mapped on chromosome 10 were used to distinguish the exogenous chromosome 10 transferred from HA(10)A cells from the endogenous chromosome 10 of the T98G cell line. As shown in Figure 4a , DNA fragments ampli®ed from the T98G and HA(10)A cells showed dierent mobilities on polyacrylamide gel electrophoresis due to length polymorphism at both D10S1779 and D10S527 loci on 10p (Figure 4a , (1) and (2), respectively). The DNA fragment containing the D10S1779 locus from HA(10)A cells was ampli®ed in clones M1 to M3 and R2 to R12, and the DNA fragment of the D10S527 locus from HA(10)A cells was detected in hybrid clones M1, M2 and R3 to R13.
In all, 20 microsatellite markers on chromosome 10 were similarly analysed and the results are summarized in Figure 4b . One of the three clones obtained from non-irradiated microcells (M2) and four of the 13 clones from irradiated microcells (R1 to R3 and R11) retained a single chromosomal fragment 10p. Among these ®ve hybrids, three clones with a decreased ability for anchorage-independent growth (M2, R3 and R2) commonly retained the region telomeric from the D10S570 locus. As observed in clone R1, retention of a chromosomal region telomeric from the loci D10S594 could not be involved in the suppressor activity. These results clearly indicated that the region¯anked by the loci D10S594 and D10S570 was necessary for the suppressor activity. The results from the other 11 hybrid clones carrying 10q as well as 10p also supported this conclusion, although the possibility could not be excluded that the phenotypes of these hybrid clones were in¯uenced by other tumor suppressor genes on 10q, including the PTEN/ MMAC1 gene on 10q23.
No suppression of colony formation in hybrid clone R11 carrying the region between D10S594 and D10S527 loci is the sole exception to this conclusion (Figure 4b) . A small deletion within the critical portion might result in loss of suppressor activity of the clone.
The region between the D10S594 and D10S570 loci determined by functional analysis included the entire region on 10p15 and a portion of the region on 10p14 detected by LOH analysis. These results strongly suggested the presence of possible glioma suppressor genes in the overlapping region determined by the two approaches.
Discussion
As well as in gliomas, allelic loss of chromosome 10 is frequently observed in prostate cancers (Ittmann, 1996; Konig et al., 1996) , renal cell cancers (Bergerheim et al., 1989) and malignant meningiomas (Rempel et al., 1993) . Among these tumors, gliomas are characteristic because more than half of them show total loss of one chromosome 10. Therefore, multiple tumor suppressor genes on the chromosome are likely to be involved in development of such tumors (Fujimoto et al., 1989; Fults et al., 1990; Sonoda et al., 1996) . Loss of a whole chromosome 10, however, does not provide any information about the subchromosomal localization of these genes. To overcome this disadvantage, we followed two separate approaches; extensive structural analysis and a functional assay for putative tumor suppressor genes.
We previously reported LOH on chromosome 10p in human gliomas (Sonoda et al., 1996) . However, commonly deleted regions could not be deduced precisely due to the limited numbers of both tumor T98G  M1  M2  M3  R1  R2  R3  R4  R5  R6  R7  R8  R9  R10  R11  R12  R13 HA ( Dowdy et al., 1987; Tanaka et al., 1991; Goyette et al., 1992; Murakami et al., 1995 . Since T98G cell lacks one entire chromosome 10, this is an appropriate recipient cell line for the present study. Colony forming ability in soft agar was examined as an indicator of malignant phenotype of the cells . Among the hybrid clones with dramatically decreased colony forming ability, some still gave small numbers of colonies (for example, G10R2, 4 and 5 in Table 2 ). These colonies might be produced by loss or damage of the transferred chromosomal fragment. This approach revealed that the 10p region carrying suppressor activity of anchorage independent cell growth included two regions most frequently deleted in LOH analysis. However, the biological analysis could not determine which of the two regions was responsible for the suppressor activity. The coincident results from two completely independent approaches strongly suggest the presence of tumor suppressor genes involved in the genesis of glioma on chromosomal regions 10p14 ± p15. Two fragments of chromosome 10 were reported to suppress tumor growth in nude mice by a functional assay involving microcell-mediated transfer of chromosome 10 fragments into dierent glioblastoma cell line, U251 (Steck et al., 1995) . One was the 10q21 ± q23 fragment from which the PTEN/MMAC1 gene was subsequently isolated and the other was 10pter-q11 fragment that overlapped that reported in the present study but contained a much larger region.
Final identi®cation of the tumor suppressor genes in the regions de®ned here will require a search for mutations in particular genes and additional functional assays using transfer of shorter 100 kb to 1 Mb DNA fragments cloned in yeast arti®cial chromosomes into cancer cells through fusion with YAC-bearing yeasts.
Materials and methods

Human tissue samples
All glioma specimens were surgically resected and histologically diagnosed at the Department of Neurosurgery, Tohoku University School of Medicine, Sendai, Japan, according to the WHO brain-tumor scheme (Kleihues et al., 1993) . The tumors included two ependymomas (grade I), 13 astrocytomas (grade II), two oligodendrogliomas (grade II), 23 anaplastic astrocytomas (grade III), three malignant ependymomas (grade III), three anaplastic oligodendrogliomas (grade III) and 33 glioblastomas (grade IV). Corresponding constitutional DNAs were obtained from peripheral blood leukocytes of each patient.
PCR analysis of microsatellite markers
DNA was extracted from tissues or cultured cells by proteinase K-phenol-chloroform extraction (Blin et al., 1976) . The 24 polymorphic microsatellite sequences examined were reported previously (Table 1 , upper panel) (Gyapay et al., 1994) . The other 16 microsatellite markers were kindly provided by Dr R White, Huntsman Cancer Institute, University of Utah (Table 1 , lower panel). Marker DNA segments that included microsatellites were ampli®ed by PCR. The 5'-end of one of a pair of primers was labeled using 32 P-ATP and polynucleotide kinase (Boehringer Mannheim). PCR products were separated by electrophoresis in denaturing 5% polyacrylamide gels containing 7 M urea, followed by autoradiography.
Subchromosomal localization of microsatellite markers
Subchromosomal localization of each marker and the genetic distances between pairs of markers were determined by PCR ± based analysis using the GENE BRIDGE 4 Radiation Hybrid Panel (Research Genetics, Huntsville). PCR for each marker sequence was performed in duplicate and the results were scored using the statistical program RHMAPPER at the Whitehead Institute for Biomedical Research (Hudson et al., 1995) .
Cell lines
The mouse-human hybrid HA(10)A, obtained from Coriell Cell Repositories, carries a human chromosome 10, tagged with a neomycin-resistance gene, as its only human material (Perhouse et al., 1993) . This donor-cell line was grown in DMEM with high glucose, supplemented with 10% fetal bovine serum and 200 mg/ml of G418 (Life Technologies). Recipient cells of a human glioblastoma cell line, T98G, were grown in EMEM supplemented with 10% fetal bovine serum, non-essential amino acids, and sodium pyruvate (Stein, 1979) .
Microcell-mediated chromosome transfer and fusion
Microcell-mediated chromosome transfer was performed as described previously (Fournier et al., 1981; Murakami et al., 1995) . The donor cell line, HA(10)A, was treated with colcemid (Sigma) at a concentration of 0.06 mg/ml for 48 h. Microcells were produced by treatment with 10 mg/ml cytochalasin B (Sigma), exposure to 0 ± 10 k Rad of girradiation, then size-selected through a series of sterile ®lters (0.8, 0.5 and 0.3 mm; Nucleopore). The ®ltrate was resuspended in medium containing 100 mg/ml phytohemaglutinin-P (Difco) and allowed to attach to monolayers of recipient T98G cells. Fusion was accomplished by treating cell layers with 50% w/w polyethylene glycol (PEG1500; Boehringer-Mannheim) for 1 min. After 48 h incubation at 378C, the cells were distributed 1 : 72 and selected in medium containing 600 mg/ml G418.
Assay for colony formation in soft agar
The cells were subjected to assay for anchorage-independent colony formation in quadruplicate, at a seeding density of 10 4 cells/60 mm diameter tissue culture dish with bilayers of 0.33% and 0.5% soft agar (agar noble; Difco). The cultures were observed the following day to ensure suspension of single cells. After 6 weeks, visible colonies were counted on each culture dish.
